All articles by arpita kala

arpita kala

Navigating data consent in the era of connected healthcare

The Internet of Medical Things (IoMT) technologies have transformed what is possible in healthcare. Tech has resulted in better patient outcomes due to faster diagnoses and personalised therapies. Inevitably though, this tech collects more sensitive data than ever before. We explore how companies and health authorities can manage the data privacy complexities of connected healthcare to build patient trust and ensure transparency.

How the life sciences sector can defend against the top five data protection challenges

Pharma and healthcare organisations use patient data to deliver personalised treatments and efficient care, but the digitalisation of the industry raises new privacy and cybersecurity concerns. We explore how the life sciences industry can address these challenges to create a secure and compliant health data ecosystem.

No more cookies: How healthcare companies can gain trust for data consent

Healthcare and life sciences companies have long relied on third-party cookies for their digital marketing. As browsers now start to block these data-tracking tools, we explore how companies can deliver personalised digital experiences by using a transparent digital approach.

Clinical trials: How AI can help providers stay TMF inspection-ready

The clinical trials industry is facing a number of hurdles, but AI and digitalisation are being heralded as key to overcoming them, particularly when it comes to preparing for inspections and audits

How effective communications can improve patient engagement in clinical trials

Successful clinical research relies on inclusion. Having participants from various backgrounds makes it possible to decipher how study findings will be applied in real-world scenarios.

“The innovation just explodes”: The role of AI in accelerating biopharma R&D

Artificial intelligence (AI) has the potential to expedite the discovery of new drugs. Using AI-powered platforms, biopharma companies can create research processes that are time and cost-efficient.

From regulations to rare diseases: Navigating the FDA review process

New legislation and technologies have stimulated the international regulatory environment to adapt to the rapidly evolving pharmaceutical sector. We explore how sponsors can best handle these developments to increase the efficiency of their clinical trials.

Healthcare’s digital transformation: Improving public trust with data sharing

Managing data privacy and security is essential for the future digitalisation of healthcare. We explore how the sector can adapt to embrace smart medical technologies while preserving patient data confidentiality.